Skip to content
Clinical Trial Events
BIO-Europe 2026

Fireside chat Biomanufacturing Strategy track

Manufacturing Next-Gen Therapeutics from Advanced Therapy Manufacturing to Novel Modalities

Tue, Nov 10, 2026 · 10:00–11:00 AM CET Biomanufacturing Strategy Stage, Koelnmesse

About this session

Examine the unique economic and operational challenges of manufacturing cell and gene therapies, mRNA products, and other advanced modalities. Explore strategies to achieve commercial viability and patient access.

Speakers

  • Birk Vanderweeen

    Senior VP, Global Manufacturing & Supply · Legend Biotech

    Speaker

  • Alex Bloom

    Chief Development Officer · AviadoBio

    Speaker

  • Paul Bravetti

    CEO · Brenus Pharma

    Speaker

  • Joana Correia

    Co-founder and CEO · Exogenus Therapeutics

    Speaker